Brca1 mRNA was detectable in female mouse mammary gland tissue from adult virgins, during pregnancy and early lactation. It was associated with phases of mammary epithelial cell proliferation and differentiation but the pattern of Brca1 expression was dissociable from that of a true differentiation marker, b-casein, by virtue of its significant expression in the virgin gland and termination of its expression in early lactation. In a primary cell culture model, association of a laminin-rich extracellular matrix (ECM) with mammary epithelial cells was required for cell survival and cell differentiation and suppressed Brca1 expression in these cells. ECM-association may significantly contribute to the final restriction in Brca1 expression in the lactating gland in vivo. Interestingly, our results suggest that mammary epithelial cells undergo apoptosis both when expressing and when not expressing Brca1, depending on whether the dying cell populations had been terminally differentiated or not. Cell Death and Differentiation (2000) 7, 360 ± 367.
Introduction
Mutations at the human breast cancer susceptibility gene (BRCA1) locus account for *45% of early-onset familial breast cancer and 80 ± 90% of inherited co-occurring breast and ovarian malignancies. 1 The murine homologue, Brca1, encodes a 1812 amino acid protein which displays 58% homology and similar charge and hydrophilic character to its human counterpart. 2, 3 BRCA1 has been variously localised to the nucleus of normal breast epithelial cells, 4 ± 8 to cylinders derived from cytoplasmic structures which anastamose through the nucleus 9 and to the secretory apparatus 10 and associated secretions. 11, 12 In addition, it has been reported to both remain in the nucleus 7 and to be present in the cytoplasm of breast cancer cell 4 ± 6 (reviewed in 13, 14 ) . Some or all of these observations may be reconciled by the hypothesis that BRCA1 transcripts are differentially spliced, 15 ± 17 and that the different mature proteins are directed to specific subcellular sites. For instance, nuclear localisation signals have been identified as encoded in exon 11 of human BRCA1 15, 18 but these are obviously absent in the common exon 11-minus splice variant (reviewed in 13 ). The occurrence in BRCA1 (and BRCA2) of a DNA-binding RING finger domain 19 in the Nterminal region 2, 3, 20 and of a transactivation domain at the Cterminus 21 ± 23 indicates that these proteins act as transcription factors. 24 This hypothesis is supported by observations which implicate BRCA1 in chromatin remodelling, 25 and reports that the protein has been associated with the histone deacetylase complex.
26 BRCA1 also appears to have a direct involvement with the process of gene transcription: it has been identified as the hSRB7 component of the holoenzyme RNA polymerase II, 27 and the BRCA1 C-terminal (BRCT) domain has been reported to associate with RNA helicase A. 28 Another function attributed to BRCA1 homologues is in the maintenance of genomic integrity, possibly through an involvement in transcription-coupled DNA repair. 29, 30 A functional relationship has been demonstrated between BRCA1 and cellular agents which mediate the resolution of double-stranded DNA breaks during recombination 31 ± 34 (see 35 ) , and BRCA1 has been localised to the centrosome during mitosis. 36 It has also been suggested that the mouse homologue, Brca1, may interact with the DNA-repair protein p53 which shows a similar pattern of expression. 37 ± 39 Brca1 carries out one or more indispensable functions in early embryogenesis and appears to be required for embryonic proliferation and the development of germ layers and neural structures. 38,40 ± 42 That a deficit in cell proliferation underlies the failure of the Brca1 (and Brca2) null embryos to survive is further suggested by their overexpression of the p21/Waf1 cyclin dependent kinase inhibitor. 41, 43 The expression of Brca1 at multiple sites of organogenesis in later embryogenesis, and in a diversity of adult tissues including the thymus, testis, breast epithelium and ovarian follicles, 37, 44 suggests an involvement for the product(s) of this gene in one or more fundamental processes of development, and that it is expressed at sites of proliferation where differentiation will soon follow. Furthermore, experimental inhibition of BRCA1 expression produced accelerated growth of normal and malignant mammary epithelial cells but not of non-mammary epithelial cells 45 and over-expression of BRCA1 produced growth retardation in vitro, specifically of breast and ovarian tumour cell lines.
The reported expression of Brca1 in postnatal mammary epithelium during puberty and pregnancy 37, 44 suggests that the gene product functions in proliferating and/or differentiated cells. Mammary transcription of the Brca1 gene has thus far been reported to be high in mid-and latepregnancy, appearing to wane upon lactation and early involution, but becoming prominent again 5 ± 7 days postweaning. 37, 44 Brca1 expression is upregulated in cultured cells from G1/S to M 47 again implying a role in proliferation. The expression of the human homologue, BRCA1, and BRCA2 would seem to be similarly cell cycle regulated with mRNA levels being increased at late G1/early S-phase, preceding DNA synthesis, in cultured cells. 15, 48, 49 The kinetics of upregulation of Brca1 expression during mammary epithelial activity in puberty and pregnancy are echoed by Brca2. 39, 47 We have investigated the levels of Brca1 mRNA in two model systems of mammary epithelial cell proliferation, differentiation and apoptosis. We show that Brca1 mRNA is expressed in the virgin, pregnant and for the first time in the early lactating gland which coincides with the time of a final burst of alveolar epithelial cell proliferation. Notably, Brca1 was not expressed in early involution when a wave of epithelial cell apoptosis occurs. In the virgin gland and at late lactation, Brca1 expression diverged sharply from that of the differentiation marker milk protein b-casein transcript, which is detected during pregnancy, lactation and early involution. In primary cultures of epithelial cells from midpregnant mammary gland tissue we found Brca1 mRNA in populations of proliferating cells and of quiescent cells which were predisposed to apoptosis. However, overlaying the quiescent population with a laminin-rich extracellular matrix which ensured cell survival and permitted cell differentiation was sufficient to suppress Brca1 expression. We hypothesise that Brca1 expression is primarily associated with proliferation, and is restricted in fully differentiated mammary epithelial cells by an ECM-integrin receptor-mediated regulatory mechanism.
Results
Whole mount analysis 50 of adult mouse mammary gland ( Figure 1A ) reveals the growth of the ductal and alveolar systems from the virginal state, through pregnancy to full development in lactation: by mid-pregnancy abundant ductal branching and strong initial alveolar development has become evident. In lactation full alveolar development has been achieved and maximum colonisation of the entire fat pad is apparent. These events reflect waves of epithelial cell proliferation during pregnancy and as late as early in lactation. 51 Weaning triggers the onset of involution that involves, sequentially, milk stasis in the alveoli, a phase of intense alveolar epithelial cell apoptosis and finally a phase of reductive glandular remodelling that is associated with significant local matrix metalloprotease activity. 52, 53 The whole mount of the 4-day involuting gland shows significant alveolar regression and this continues with time ( Figure 1A and results not shown).
The proliferation of the alveolar mammary epithelial cells during pregnancy is accompanied by gradual asynchronous differentiation of the cells as pregnancy progresses. 54 The differentiation of the alveolar element of the mammary gland can be followed by following the appearance of transcripts of milk protein genes as the gland develops. 52 Figure 1B charts the analysis of b-casein transcripts in total mRNA isolated from virgin, pregnant, lactating, and involuting mammary gland by RT ± PCR using a limited cycle-number PCR. Under these conditions no b-casein transcripts were detectable in the virgin gland, but transcript was detectable from 8 days of pregnancy onwards through lactation and early involution eventually becoming undetectable after 8 days of involution (see also 52 ). It has been of interest to attempt to associate Brca1 expression with either the proliferating and/or proliferating and differentiated states of the mammary epithelial cell. 37, 39, 47 RT ± PCR analysis of Brca1 transcripts ( Figure 1B) show their presence to be dissociated from that of b-casein transcripts. Brca1 transcripts are detectable in adult virgin glands where we did not detect b-casein; generally, Brca1 and b-casein expression parallel each other during pregnancy. However, we here and others 37 report relatively low levels of Brca1 expression at day 14 of pregnancy. At this time b-casein expression would seem maintained. The event that dictates this reduction in Brca1 transcript levels remains unclear. In this report, for the first time, the presence of Brca1 transcripts has been investigated in early lactation, and are found to be present. Knight and Peaker 51 have shown that a final surge in epithelial cell proliferation occurs early in lactation. It is not known what drives this phase of epithelial cell proliferation but Brca1 expression may very well accompany it. Thereafter, Brca1 and b-casein expression diverge. Brca1 transcripts were not again detectable until 4 and 8 days after weaning when they were detectable at trace levels. b-casein expresion on the other hand is maintained throughout lactation and is eventually lost at day 8 of involution. Notably, Brca1 was not expressed in early involution (day 2) when a wave of epithelial cell apoptosis occurs. 51 Figure 1C demonstrates the specificity of the Brca1 PCR measurement; the first panel shows the digestion of the RT ± PCR product at a predicted unique internal Ear1 site (see cartoon); the second panel shows the result of a Southern blot of the Ear1 digestion products and target DNA using an internal probe which detects the target DNA band and the 303 bp product, as predicted. The third panel shows the result of a hemi-nested PCR with: the primary PCR product (535 bp) as template; the`Southern probe' oligonucleotide as forward primer and using the primary PCR reverse primer. This generates a single band of 366 bp, as predicted (lanes 4 and 5). We therefore judge our Brca1 RT ± PCR products from the tissue samples and the primary cell cultures to validly reflect cellular Brca1 transcripts.
A series of studies have used cell culture systems to model the proliferative, differentiative/surviving and apoptotic fates of the alveolar mammary epithelial cell. 55 ± 57 These studies emphasise the capacity of laminin-rich extracellular matrix to support both the survival and differentiation of these mammary epithelial cells (in the presence of (b2)). This analysis is corroborated by the measurement of genomic DNA fragmentation by the TUNEL end-labelling technique using flow cytometric analysis of fluorescence ( Figure 2B ): ECM overlay suppressed the extent of DNA end-labelling detectable in cells not overlaid with ECM. As there was a significant and obvious loss of cells into the medium from the populations cultured in the absence of ECM-overlay, FACS and TUNEL/FACS analysis was carried out both on thè floating cells' in the medium and those remaining adherent, in this study. The population of proliferating cells showed the expected FACS cell cycle pattern of DNA-associated PI fluorescence ( Figure 2A ) and a low level of genomic DNA fragmentation. Survival of the cells could be ensured by substituting laminin overlay for EHS-Matrigel matrix but not by culturing the cells on a collagen matrix. 58 As well as providing a survival stimulus, it is well known that association of ECM with such mammary epithelial cells is permissive for differentiation responses (e.g. the expression and ECM-overlaid cells. Graph shows exent of terminal transferase (TdT) fluorescent labelling of free 3'-OH ends generated by DNA-fragmentation. Data are presented as fold induction in incorporation of FITC label over control (samples from the same culture plate to which no TdT was added). Data for each culture condition were generated from three independent experiments; and (C) Brca1 expression in primary cultured mouse mammary epithelial cells. RT ± PCR analysis of neu, Bax, b-casein, WAP, Brca 1 and gpdh in total RNA samples from proliferating (P), apoptotic (7E) or ECM-overlaid (+E) cultured primary mammary epithelial cells. Results of gpdh analysis at 25 cycles of amplification and where RT was omitted from the first strand synthesis step are also presented. The Brca1 RT ± PCR analysis presented is representative of six independent experiments ECM suppresses Brca1 expression FC O'Connell and F Martin of milk protein genes in the presence of lactogenic hormones): 55, 57 In Figure 2C it can be seen that transcripts of milk protein genes, b-casein and WAP (panels 3 and 4), are detectable in the population of cells cultured in the presence of ECM overlay and lactogenic hormones but not in the proliferating cells or those cultured in the absence of ECM overlay (panels 3 and 4). We could additionally define that expression of transcripts encoding the oncoprotein receptor, neu, was only detectable in the proliferating cells ( Figure 2C, panel 1) . Furthermore, transcripts for the apoptosis associated protein, Bax, were detectable in the proliferating and apoptotic cell populations but were undetectable after ECM-overlay (panel 2). Against this background we analyzed Brca1 transcripts in the primary cultured cells (panel 5): transcripts were detected in the proliferating cells, and in the population of cells not overlaid with ECM but were not detectable in the ECM-overlaid cells. (gpdh transcripts were equally detectable in all three cell populations (panel 6)). These results suggest that overlay of primary mammary epithelial cells with laminin-rich ECM which ensures cell survival and is permissive for cell differentiation is also sufficient to suppress Brca1 gene expression. We hypothesise that ECM (laminin) interactions with b 1 -integrin receptors 55,59 ± 61 on the alveolar epithelial cell membrane contributes significantly to the suppression of Brca1 expression in later lactation ( Figure 1B) . In summary our results lead us to three major conclusions: (1) That Brca1 expression in both model systems studied, in vivo and in vitro (primary cell culture), is primarily linked to cell proliferation; (2) That Brca1 expression in both model systems studied is repressed in the fully differentiated,`surviving', mammary epithelial cell; with cell interaction with laminin-rich ECM being shown for the first time to be central to this repression; and (3) That Brca1 expression in populations of mammary epithelial cells committed to apoptosis may differ depending on the cells physiological status: where the apoptotic population has been previously associated with ECM no Brca1 expression is seen; where the apoptotic population has not been associated with matrix Brca1 expression is maintained.
Discussion
The data reported here for both the in vivo and cell culture studies suggest that Brca1 expression is primarily linked to mammary epithelial cell proliferation. In vivo, expression is seen in the virgin animals, during a period reported to exhibit active epithelial cell proliferation in the terminal end buds, structures associated with the establishment of the mature mammary tree. 62, 63 Expression was also seen in early and late pregnancy; the former period associated with intense branched ductal expansion, the latter with alveologenesis and differentiation. Additionally, expression is reported for the first time during the final proliferative pulse, 51 at the beginning of lactation. Finally, we show Brca1 expression in primary cultures of mid-pregnant mammary epithelial cells proliferating in the presence of foetal calf serum and EGF ( Figure 2C ). The pattern of Brca1 expression reported here for the mouse mammary gland is similar (but extends to early lactation) that reported by Marquis et al 37 and Rajan et al 47 and parallels the expression pattern reported for Brca2. 39, 47 These authors have also reported Brca1 expression in proliferating mammary epithelial HC11 cells. 37, 47 Particularly interesting is the finding in this and the latter studies that Brca1 expression would seem to accompany mammary epithelial cell proliferation whenever it occurs, and it occurs in the gland under a range of differing humoral and local influences (i.e. in the TEB of the virgin, during early and late pregnancy, and early in lactation). That the Brca1 expressed in the mammary gland during periods of avid proliferation is absolutely required for mammary gland development has been demonstrated by Xu et al 64 who selectively restricted full-length Brca1 isoform production in pregnant mammary gland using the Cre ± loxP recombination system under the control of the Wap and MMTV promoters. Without the full-length Brca1 isoform, mammary tissue failed to fully develop during pregnancy: The ductal tree formed incompletely and failed to fully penetrate the mammary fat pad and there was a frequent increase in apoptosis. The authors felt that cellular loss of fulllength Brca1 isoform deprived the cells of a crucial genomè caretaker'. This would result in frequent genetic alterations and cell loss by apoptosis, triggered by`gatekeepers' such as p53. That these animals also succumbed to mammary tumours strengthened their case. The Brca1 molecular machinery may also contribute significantly to alveologenesis: This is suggested by the observation that BARD-1-deficient mammary epithelial cell clones lost the capacity to form luminal structures in three-dimensional collagen gels. BARD1 (BRCA1-associated RING domain protein) was identified as a protein which functionally interacts with BRCA1.
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Brca1 expression in both model systems studied was repressed in the fully differentiated cells ( Figures 1B and 2C) ; with cell interaction with the laminin-rich ECM being most likely responsible for this repression. The association of the mammary epithelial cell with the laminin-rich ECM through occupation of b 1 -integrin receptors provides a strong survival signal to the mammary epithelial cell 56, 57 at least in part through activating an insulin/IGF-1 modulated anti-apoptotic PI-3 kinase/Akt transduction cascade. 65 ± 67 Mammary epithelial cells in primary culture require both ECM-association and insulin (or IGF-1) for survival. 56 , 57 Farrelly et al 61 have demonstrated the ECM-survival stimulus to act through insulin/IGF-1-regulated PI 3 kinase pathway-dependent signalling. The pathway would presumably regulate the activity of pro-or anti-apoptotic members of the Bcl 2 family of proteins. Additionally, ECM-cell contacts are suggested to affect nuclear shape (and gene expression) by determining stress fibre tensility through the formation of focal adhesions. 68 This may impact on rates of transcription of specific genes. For instance, it has been possible to define elements within the promoters of the b-casein and TGF-b genes that are ECM-sensitive, the former mediating a positive response, 69, 70 the latter a negative response 71 to mammary epithelial cell-ECM association. Perhaps it is by such a mechanism that ECM suppression of Brca1 expression occurs.
A comparison of Brca1 expression in the two model systems studied revealed that Brca1 expression in populations of mammary epithelial cells committed to apoptosis seems to differ depending on the cell populations physiolo-ECM suppresses Brca1 expression FC O'Connell and F Martin gical status. In the population of fully differentiated alveolar epithelial cells which predominate in lactation we observed that Brca1 expression becomes repressed after the final wave of proliferation of early lactation ( Figure 1B ). This is most likely regulated by ECM-cell interaction ( Figure 2C ). In this, the population of cells lost by apoptosis in early involution, Brca1 expression remains suppressed. It is interesting that while the expression of a variety of cell cycle/ G1 associated genes become activated in early involution-associated apoptosis 52, 72, 73 Brca1 expression remains repressed. Although there is no gross destruction of ECM as yet in the early involuting gland that exhibits high levels of apoptosis (e.g. the two day involuting gland 52 ), it is likely that there might be change in the status of lamininintegrin receptor interactions at this time, thus, it is not clear that ECM-cell associations are responsible for maintaining this repression of Brca1 expression. The mammary gland of early parturition of the conditional Brca1 knockout mouse exhibits high levels of apoptosis. 64 This parallels our findings in early involution and might support a hypothesis that the Brca1-minus state is`pro-apoptotic' for differentiated mammary alveolar epithelial cells. However, the increased apoptosis seen in the knockout mouse at early parturition might reflect the clearing of a population of cells with DNAdamage that arose during the last wave of`proliferation without an intact cell cycle surveillance system.' In the cell culture model (Figure 2 ) Brca1 expression persisted after cell proliferation has ceased, in a population of cells that are quiescent, exposed to`lactogenic hormones (prolactin, hydrocortisone and the required survival factor, insulin) but are undergoing extensive apoptosis because of a lack of association with a suitable laminin-rich ECM. As the Brca1 expression measurements were made 48 h after removal of the growth factors (serum and EGF) we feel the persistent Brca1 expression is not residual to the effects of growth factor exposure during proliferation. Other growth factor responses, e.g. Erk1/Erk2 activation, are lost within 6 h of growth factor removal (D Finlay and F Martin, unpublished observation). It is important to note that the cell culture experiment (Figure 2 ) does not model a transition of mammary epithelial cells from differentiated to apoptotic state (equivalent to the lactation to involution transition) but rather demonstrates the rescue by suitable ECM-association of a cell population that will otherwise die due to lack of this survival influence. This experiment shows that apoptosis of mammary epithelial cells can also occur in the presence of Brca1 expression, but, in cells in which Brca1 expression has not previously been repressed by terminal differentiation. This apoptotic population expressing Brca1, were it being considered to directly reflect a physiological population may parallel those cells in the terminal end-bud of the young adult virgin gland which when`non-differentiated' in the bud, die by apoptosis while another population proliferate and survive to contribute to branching of the mammary tree. 63 Interestingly these latter cells would die at a time when the glandular Brca1 expression is high ( Figure 1B) . Thus, our study suggests that Brca1 expression is most likely associated with proliferation in the mammary gland; it may be permitted in the dying population of the terminal end bud but it is finally repressed in the gland at lactation which is quantitatively dominated by a population of alveolar epithelial cells most of which are not again going to re-enter the cell cycle but will die by apoptosis.
Materials and Methods
Mammary tissue dissected from virgin (5-week-old), pregnant, lactating and weaned CD1 mice was snap frozen in liquid nitrogen and stored at 7708C for subsequent RNA preparation. A fourth (inguinal) mammary gland was used for methacarn fixed, carmalum stained whole mount preparation, as described by Edwards et al. 50 Primary mammary epithelial cell cultures 59, 74, 75 were prepared from mammary glands from 14 ± 19 day pregnant CD-1 mice, as recently described. 57 After growing under`proliferating' conditions for 48 h, populations of`apoptotic cells (`minus ECM')', cultured in the absence of serum and EGF and the absence of ECM (Matrigel) overlay but in the presence of lactogenic hormones and`surviving/differentiated cells (`plus ECM')' cultured in the absence of serum and EGF, but in the presence of ECM (EHS tumour-derived ECM, Matrigel (Becton Dickinson)) overlay and lactogenic hormones, were prepared. 57 These were subsequently harvested for FACS-cell cycle analysis, FACS/TUNEL and total RNA isolation and RT ± PCR analysis. FACScell cycle analysis was carried out as recently described. 57 For FACS/TUNEL 76 analysis cultured cells were recovered from the medium by centrifugation or gently scraped off into PBS and pelleted. They were resuspended in a 1% solution of formaldehyde in PBS and fixed on ice for 15 min, washed in PBS, resuspended in icecold 70% ethanol and left at 48C for at least 30 min. The cells were washed in PBS and resuspended in 50 mL TdT reaction medium (37.8 mL H 2 O; 5 mL 106TdT buffer (300 mM Tris base, 1.4 M sodium cacodylate (pH 7.2)) and 10 mM cobalt chloride); 5 mL cobalt chloride (25 mM); 2 mL biotinylated-16-dUTP (1 nM) and 0.2 mL TdT (25 U.mL 71 ). The samples were incubated at 378C for 30 min, then washed in PBS and resuspended in staining buffer (54.2 mL MilliQ water; 25 mL 206SSC; 20 mL 25% BLOTTO; 0.7 mL FlTC-conjugated Extravidin (Sigma) and 0.1 mL Triton X-100) and stained in the dark at 378C for 30 min. The cells were then washed and stored in PBS at 48C, in the dark, until analyzed in a FACStar Plus flow cytometer. Total RNA was prepared by the method of Chomczynski and Sacchi 77 from snap frozen mouse mammary tissue and primary cultured cells, treated as outlined above. Aliquots of total RNA were treated with RNase-free DNase I (Boehringer Mannheim) and the RNA concentration determined spectrophotometrically. 2 ± 10 mg of DNase I-treated total RNA was transcribed with Superscript 2 II RNase H-minus reverse transcriptase (GibCo BRL) in the presence of 100 ng ± 1 mg of the appropriate reverse primer. Ten per cent of the first strand cDNA synthesis reaction was used as template for PCR in a Taq catalysed amplification using the appropriate primer pairs: for Brca1, fwd: 5' TCGGCGCTTGCAAGTACGGATCT 3' ; rev: 5' AAGGTTAGA-CAGCTGGACACCTA 3' (see Figure 1) ; for b-casein, fwd: 5' GCCTTGCCAGTCTTGCTA 3' ; rev: 5' GGAATGTTGTGAGTGGC 3'; 78 for WAP, fwd: 5' AAAAGCCAGCCCCATTGA 3'; rev: 5' AGGGTTATCACTGGCACT 3'; 78 for Bax, fwd: 5' GGTTTCATCCAG-GATCGAGCAG 3'; rev: 5' CCGTCTGGCACTGGTAGA 3'; 56 for gpdh, fwd: 5' CCTTCATTGACCTCAACTAC 3'; rev: 5' TTCACACCCATCA-CAAAC 3'; 78 and for neu, fwd: 5' CGGAACCCACATCAGGCC 3'; rev: 5' TTTCCTGCAGCAGCCTAC 3'. 79 Taq polymerase addition was witheld until after a`hot start' cycle, 958C for 2 min and cooling to 808C after which the enzyme was added. Each PCR cycle consisted of a denaturing step at 958C for 30 s, an annealing step at 52 ± 608C (optimised for individual primer pairs) for 45 s and a primer elongation step at 728C for 80 s. Depending on the abundance of target mRNA present in the starting sample, 18 ± 40 cycles of PCR amplification were carried out.
